homocysteine has been researched along with Apolipoprotein B-100, Familial Defective in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (47.06) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Derfler, K; Sinzinger, H; Steiner, S | 1 |
| Hardersen, R; Hovland, A; Lappegård, KT; Mollnes, TE; Nielsen, EW | 1 |
| Bilgir, F; Bilgir, O; Calan, M; Calan, O; Cinali, T; Gonen, MS; Kebapcilar, L; Kulac, E | 1 |
| Buirma, RJ; de Sauvage Nolting, PR; Defesche, JC; Hutten, BA; Kastelein, JJ; Lansberg, PJ | 1 |
| Blessing, F; Fraunberger, P; Seidel, D; Uberfuhr, P; Walli, AK; Wang, Y | 1 |
| Bertolini, S; Cortese, C; Federici, G; Gnasso, A; Irace, C; Liberatoscioli, L; Mannucci, L; Pastore, A; Pisciotta, L | 1 |
| McCully, KS; Olszewski, AJ | 1 |
| Bønaa, KH; Joakimsen, O; Leren, TP; Ose, L; Russell, D; Stensland-Bugge, E; Tonstad, S | 1 |
| Knudtzon, J; Ose, L; Refsum, H; Sivertsen, M; Tonstad, S | 1 |
| Refsum, H; Tonstad, S; Ueland, PM | 1 |
| Kastelein, JJ; Koomans, HA; Rabelink, TJ; van Dam, T; Verhaar, MC; Wever, RM | 1 |
| Ose, L; Refsum, H; Tonstad, S; Ueland, PM | 1 |
| Berg, K | 1 |
| Chehne, F; Kritz, H; Schmid, P; Sinzinger, H | 1 |
| Gromeier, S; Herrmann, W; Julius, U; Pietzsch, J; Schorr, H | 1 |
| Finckh, B; Klein, M; Kohlschütter, A; Ullrich, K; Wittenstein, B | 1 |
1 review(s) available for homocysteine and Apolipoprotein B-100, Familial Defective
| Article | Year |
|---|---|
[Molecular biology in the diagnosis of cardiovascular diseases].
Topics: Biomarkers; Cardiovascular Diseases; DNA Mutational Analysis; Fibrinogen; Genetic Variation; Homocysteine; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipids; Molecular Biology; Polymorphism, Genetic; Risk Factors | 1998 |
6 trial(s) available for homocysteine and Apolipoprotein B-100, Familial Defective
| Article | Year |
|---|---|
Fish oil decreases serum homocysteine in hyperlipemic men.
Topics: Adult; Apolipoproteins B; Cholesterol; Fish Oils; Homocysteine; Humans; Hyperlipoproteinemia Type II; Hypertriglyceridemia; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Triglycerides | 1993 |
Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia.
Topics: Anticholesteremic Agents; Child; Cholestyramine Resin; Double-Blind Method; Energy Intake; Female; Growth; Homocysteine; Humans; Hyperlipoproteinemia Type II; Male | 1996 |
5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia.
Topics: Adult; Biological Availability; Dose-Response Relationship, Drug; Endothelium; Female; Folic Acid; Hemodynamics; Homocysteine; Humans; Hyperlipoproteinemia Type II; Hypoxanthine; Male; Nitric Oxide; Nitric Oxide Synthase; Recombinant Proteins; Superoxides; Tetrahydrofolates; Vasodilation; Xanthine Oxidase | 1998 |
The C677T mutation in the methylenetetrahydrofolate reductase gene predisposes to hyperhomocysteinemia in children with familial hypercholesterolemia treated with cholestyramine.
Topics: Anticholesteremic Agents; Child; Cholestyramine Resin; Female; Folic Acid; Genotype; Heterozygote; Homocysteine; Homozygote; Humans; Hyperlipoproteinemia Type II; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Oxidoreductases Acting on CH-NH Group Donors | 1998 |
[Unaltered homocysteine levels during simvastatin therapy].
Topics: Adult; Anticholesteremic Agents; Arteriosclerosis; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Female; Homocysteine; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Risk Factors; Severity of Illness Index; Sex Factors; Simvastatin; Smoking; Time Factors; Treatment Outcome; Triglycerides | 2000 |
Homocysteine levels in patients treated with lipid apheresis: effect of a vitamin therapy.
Topics: Adult; Cystathionine; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipoproteinemia Type II; Lipids; Male; Vitamin B 12; Vitamin B 6 | 2001 |
10 other study(ies) available for homocysteine and Apolipoprotein B-100, Familial Defective
| Article | Year |
|---|---|
Pleiotropic effects of regular lipoprotein-apheresis.
Topics: Albuminuria; Biomarkers; Blood Component Removal; Brachial Artery; Dextran Sulfate; Endothelial Progenitor Cells; Female; Homocysteine; Humans; Hyperlipoproteinemia Type II; Kidney; Lipoproteins; Male; Middle Aged; Recovery of Function; Retrospective Studies; Severity of Illness Index; Stroke Volume; Time Factors; Treatment Outcome; Vasodilation; Ventricular Function, Left | 2017 |
Hematologic and hemostatic changes induced by different columns during LDL apheresis.
Topics: Adult; Antithrombin III; Blood Component Removal; Cholesterol, LDL; Female; Fibrinogen; Hemostasis; Homocysteine; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Peptide Hydrolases; Plasminogen Activator Inhibitor 1 | 2010 |
Examination of adhesion molecules, homocysteine and hs-CRP in patients with polygenic hypercholesterolemia and isolated hypertriglyceridemia.
Topics: Adult; C-Reactive Protein; Case-Control Studies; Cell Adhesion Molecules; E-Selectin; Female; Homocysteine; Humans; Hyperlipoproteinemia Type II; Hypertriglyceridemia; Intercellular Adhesion Molecule-1; Male; Middle Aged; Multifactorial Inheritance; P-Selectin; Risk Factors; Vascular Cell Adhesion Molecule-1 | 2011 |
Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia.
Topics: Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Female; Homocysteine; Humans; Hyperlipoproteinemia Type II; Lipids; Male; Middle Aged; Netherlands; Prevalence; Risk Factors | 2003 |
Effects of heparin-mediated extracorporeal low-density lipoprotein precipitation beyond lowering proatherogenic lipoproteins--reduction of circulating proinflammatory and procoagulatory markers.
Topics: Arteriosclerosis; Blood Coagulation Factors; Blood Component Removal; C-Reactive Protein; CD40 Antigens; Cell Adhesion Molecules; Female; Homocysteine; Humans; Hyperlipoproteinemia Type II; Inflammation Mediators; Lipoproteins, LDL; Male; Middle Aged | 2004 |
Serum homocysteine, methylenetetrahydrofolate reductase gene polymorphism and cardiovascular disease in heterozygous familial hypercholesterolemia.
Topics: Adult; Aged; Coronary Artery Disease; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperlipoproteinemia Type II; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Odds Ratio; Polymorphism, Genetic; Regression Analysis; Risk Factors; Sex Factors | 2005 |
Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects.
Topics: Adolescent; Anthropometry; Apolipoproteins B; Arteriosclerosis; Carotid Arteries; Carotid Stenosis; Child; Female; Fibrinogen; Homocysteine; Humans; Hyperlipoproteinemia Type II; Lipoprotein(a); Male; Norway; Puberty; Risk Factors; Sex Factors; Ultrasonography | 1996 |
Association between plasma total homocysteine and parental history of cardiovascular disease in children with familial hypercholesterolemia.
Topics: Adolescent; Age Distribution; Cardiovascular Diseases; Child; Diet; Family Health; Female; Folic Acid; Heterozygote; Homocysteine; Humans; Hyperlipoproteinemia Type II; Lipids; Male; Methylenetetrahydrofolate Reductase (NADPH2); Multivariate Analysis; Oxidoreductases Acting on CH-NH Group Donors; Parents; Point Mutation; Prevalence; Risk Factors; Sex Distribution; Vitamin B 12 | 1997 |
Heart lines. Flexible arteries and folic acid.
Topics: Arteries; Elasticity; Folic Acid; Hematinics; Homocysteine; Humans; Hyperlipoproteinemia Type II | 1999 |
Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia.
Topics: Adolescent; Adult; Antioxidants; Ascorbic Acid; Child; Child, Preschool; Cholesterol; Chromatography, High Pressure Liquid; Coenzymes; Diabetes Mellitus, Type 1; Female; Glycogen Storage Disease Type I; Hemoglobins; Homocysteine; Humans; Hyperlipoproteinemia Type II; Infant; Lipoproteins, LDL; Male; Malondialdehyde; Sulfhydryl Compounds; Triglycerides; Ubiquinone; Uric Acid; Vitamin E | 2002 |